TrialThe Prostate2025

Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer.

Andre Gouveia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.